Sleep treatment breakthrough: Insomnia therapy improves depression, chronic pain

Insomnia affects vulnerable populations disproportionately, including women experiencing hormonal changes, older adults, and those with lower socioeconomic status, limiting their access to effective treatments.
Insomnia could be its own problem entirely, demanding its own solution.
Scientists recognized that sleeplessness was not always a side effect of other illnesses but an independent disorder requiring direct treatment.

Por séculos, a insônia foi tratada como sombra de outras doenças — um sintoma a ser ignorado enquanto se combatia a causa raiz. Nas últimas duas décadas, porém, a ciência reescreveu esse entendimento: a insônia é um distúrbio independente, e tratá-la pode aliviar depressão, dor crônica e estresse pós-traumático. O conhecimento existe, a terapia funciona — o que falta, como tantas vezes na história da medicina, é a ponte entre a descoberta e quem mais precisa dela.

  • Cerca de um terço dos adultos sofre de insônia frequente, e a condição quase nunca aparece sozinha — ela caminha ao lado de depressão, dor crônica, ansiedade e doenças metabólicas.
  • Durante décadas, médicos trataram a insônia como consequência de outros males, ignorando-a como problema próprio — e os pacientes pagaram o preço com noites sem fim e doenças que não melhoravam.
  • A terapia cognitivo-comportamental para insônia é altamente eficaz, mas permanece inacessível para a maioria: poucos médicos foram treinados nela, o financiamento é escasso e os medicamentos disponíveis carregam riscos sérios de dependência e comprometimento cognitivo.
  • Mulheres, idosos e pessoas de menor renda são os mais afetados e os que menos conseguem chegar ao tratamento adequado — uma injustiça que se repete em camadas biológicas, psicológicas e sociais.
  • Versões online e gratuitas da terapia existem e representam uma saída real para quem está excluído das clínicas, mas a distância entre quem sofre e quem recebe cuidado ainda é enorme.

Por grande parte da história humana, a insônia foi um tormento silencioso e privado. Nas últimas duas décadas, porém, pesquisadores reescreveram profundamente o que sabemos sobre ela. A mudança não é pequena: abriu caminho para tratar condições que pareciam intratáveis — depressão, dor crônica, estresse pós-traumático — ao cuidar do sono que estava quebrado desde o início.

Cerca de um terço dos adultos na Inglaterra relata insônia frequente. A condição quase nunca viaja sozinha: quem passa a noite acordado tem alta probabilidade de conviver também com diabetes, hipertensão, ansiedade ou depressão. Por décadas, médicos chamavam isso de insônia secundária — um efeito colateral a ignorar enquanto se tratava a doença principal. A lógica parecia sólida. Não funcionou.

No início dos anos 2000, pesquisadores perceberam o que o antigo modelo havia perdido: a insônia podia chegar antes da outra doença, sobreviver a ela, ser um problema inteiramente seu. Essa virada acumulou evidências de que tratar o sono melhorava a depressão, aliviava a dor crônica, suavizava os sintomas do trauma. Tratar o sono era tratar a pessoa.

Mas a insônia não se distribui de forma igualitária. Mulheres a enfrentam mais — por mudanças hormonais, gestação, menopausa, o peso do cuidado e taxas mais altas de depressão e ansiedade. Idosos também. E pessoas com menos recursos econômicos, mais ainda. Esses grupos encontram uma colisão de pressões biológicas, psicológicas e sociais que conspiram para mantê-los acordados.

O tratamento mais eficaz disponível é a terapia cognitivo-comportamental para insônia, um programa estruturado para reformular pensamentos e comportamentos em torno do sono. Funciona em todas as populações. Ainda assim, permanece raro: a maioria dos médicos nunca foi treinada nele, o financiamento é escasso. Quem não consegue acesso à terapia recorre a remédios — que trazem riscos de dependência, comprometimento cognitivo e sintomas de abstinência. Uma nova classe de medicamentos chegou ao Reino Unido em 2022 com perfil mais seguro, mas seus efeitos de longo prazo ainda são desconhecidos.

Versions online e gratuitas da terapia existem e oferecem uma alternativa real para quem está excluído das clínicas. Em vinte anos, a medicina aprendeu a tratar a insônia. O trabalho agora é garantir que quem precisa desse tratamento consiga, de fato, alcançá-lo.

For most of human history, sleeplessness has been a private torment. But over the past two decades, scientists have fundamentally rewritten how we understand what happens when sleep stops coming. The shift is not small. It has opened a door to treating conditions that seemed untreatable—depression, chronic pain, post-traumatic stress—by fixing the sleep that was broken all along.

About one-third of adults in England now report frequent insomnia. The condition almost never travels alone. A person lying awake at night is statistically likely to be managing diabetes, high blood pressure, thyroid disease, chronic pain, anxiety, or depression alongside their sleeplessness. For decades, doctors called this secondary insomnia—a side effect of something else, a symptom to ignore while treating the primary disease. The assumption was logical: fix the underlying condition, and sleep would return. It did not work that way.

In the early 2000s, researchers began to notice something the old framework had missed. Insomnia could arrive before the other illness. It could outlast it. It could be its own problem entirely, demanding its own solution. This recognition—that insomnia was not always a consequence but often an independent disorder—changed everything. Scientists accumulated evidence showing that when people got help with their sleep, their depression improved. Their chronic pain eased. Their post-traumatic stress symptoms softened. Treating the sleep treated the person.

But insomnia does not distribute itself evenly. Women experience it more than men, often through a cascade of biological events: hormonal shifts, pregnancy, menopause, the physical and emotional weight of caregiving, higher rates of depression and anxiety, and the trauma of domestic violence. Older adults face it more. People with fewer economic resources face it most. These groups encounter a collision of biological, psychological, and social pressures that conspire to keep them awake.

One of the cruelest habits people develop during insomnia is staying in bed, trying harder to sleep. Researchers found that lying awake in the dark teaches the brain to stop associating the bed with rest. The solution sounds almost absurdly simple: if sleep will not come after twenty minutes, get up. Read. Write. Listen to music. Do something calm and absorbing. Return to bed only when drowsiness arrives. A short afternoon nap—no more than twenty minutes—is acceptable if exhaustion demands it, though even this carries risk, potentially making nighttime sleep harder still.

The most effective treatment available is cognitive-behavioral therapy for insomnia, a structured program designed to reshape both thought and behavior around sleep. It works across all populations. It works better in people whose insomnia is newer, whose depression is lighter, whose expectations are hopeful. Yet it remains scarce. Most doctors have never been trained in it. Funding is thin. The result is that people who cannot access therapy turn to pills.

Sleep medications carry a weight of consequence. Traditional sedatives impair cognition and motor control, increase fall risk, create dependence, trigger withdrawal symptoms, and leave people foggy the next day. A newer class called dual orexin receptor antagonists showed promise when they arrived in Britain in 2022, with a better safety profile around addiction. But they are new enough that no one yet knows what long-term use looks like. They are not harmless. They are not light.

Online versions of cognitive-behavioral therapy for insomnia exist and are free. For people locked out of clinics, they offer a real alternative. Yet the gap between those suffering and those receiving care remains vast. Over twenty years, medicine has learned how to treat insomnia. The work now is making sure the people who need that treatment can actually reach it.

Insomnia rarely occurs in isolation; most people with sleep problems also experience depression, chronic pain, anxiety, or other health conditions.
— Research findings cited in the article
Treating insomnia can lead to measurable improvements in depression, chronic pain, post-traumatic stress, and other conditions.
— Scientists studying sleep disorders
La Conversación del Hearth Otra perspectiva de la historia
Inventor

Why did doctors stop treating insomnia when it showed up alongside another disease?

Model

They thought it was just a symptom—like a fever from an infection. Fix the infection, the fever goes away. They assumed the same logic applied to sleep. It didn't.

Inventor

And now you're saying treating the sleep actually fixes the other things?

Model

Not fixes, exactly. But improves them significantly. Depression lifts. Pain becomes manageable. It's as if the insomnia was amplifying everything else, and sleep restores some baseline the body needs to heal.

Inventor

Who suffers most from this?

Model

Women disproportionately. Hormonal changes, pregnancy, menopause, caregiving roles, higher rates of depression and anxiety—it all compounds. Then older people, then people with less money. The vulnerability stacks.

Inventor

So there's a treatment that works?

Model

Cognitive-behavioral therapy for insomnia. Highly effective. But almost no one can access it. Doctors don't know how to deliver it. There's no funding. So people get pills instead.

Inventor

Are the pills bad?

Model

They work in the short term, but they carry real risks—dependence, cognitive fog, falls, especially in older people. The newer ones are better, but we don't have long-term data yet. They're not a solution.

Inventor

What can someone actually do if they can't sleep?

Model

Get out of bed. Don't lie there fighting it. Read, write, breathe. Do something calm. Go back only when sleep feels close. And there are free online versions of the therapy now, if someone can find them.

Inventor

So the barrier is just access?

Model

Entirely. The medicine exists. We know it works. We just haven't built the system to deliver it to the people who need it most.

Contáctanos FAQ